Literature DB >> 24320778

ASVCP guidelines: quality assurance for point-of-care testing in veterinary medicine.

Bente Flatland1, Kathleen P Freeman, Linda M Vap, Kendal E Harr.   

Abstract

Point-of-care testing (POCT) refers to any laboratory testing performed outside the conventional reference laboratory and implies close proximity to patients. Instrumental POCT systems consist of small, handheld or benchtop analyzers. These have potential utility in many veterinary settings, including private clinics, academic veterinary medical centers, the community (eg, remote area veterinary medical teams), and for research applications in academia, government, and industry. Concern about the quality of veterinary in-clinic testing has been expressed in published veterinary literature; however, little guidance focusing on POCT is available. Recognizing this void, the ASVCP formed a subcommittee in 2009 charged with developing quality assurance (QA) guidelines for veterinary POCT. Guidelines were developed through literature review and a consensus process. Major recommendations include (1) taking a formalized approach to POCT within the facility, (2) use of written policies, standard operating procedures, forms, and logs, (3) operator training, including periodic assessment of skills, (4) assessment of instrument analytical performance and use of both statistical quality control and external quality assessment programs, (5) use of properly established or validated reference intervals, (6) and ensuring accurate patient results reporting. Where possible, given instrument analytical performance, use of a validated 13s control rule for interpretation of control data is recommended. These guidelines are aimed at veterinarians and veterinary technicians seeking to improve management of POCT in their clinical or research setting, and address QA of small chemistry and hematology instruments. These guidelines are not intended to be all-inclusive; rather, they provide a minimum standard for maintenance of POCT instruments in the veterinary setting.
© 2013 American Society for Veterinary Clinical Pathology and European Society for Veterinary Clinical Pathology.

Entities:  

Keywords:  Allowable total error; bench-top; handheld; in-clinic; near-patient; quality control

Mesh:

Year:  2013        PMID: 24320778     DOI: 10.1111/vcp.12099

Source DB:  PubMed          Journal:  Vet Clin Pathol        ISSN: 0275-6382            Impact factor:   1.180


  8 in total

1.  Assessment of the CoaguChek-XS portable prothrombin time point-of-care analyzer for horses.

Authors:  Noa Berlin; Efrat Kelmer; Gilad Segev; Itamar Aroch; Gal Kelmer
Journal:  J Vet Diagn Invest       Date:  2019-03-11       Impact factor: 1.279

2.  The association between serial point-of-care test results and hospitalization time in canine parvovirus infection (2003-2015).

Authors:  Nolan V Chalifoux; Hilary J Burgess; Kevin L Cosford
Journal:  Can Vet J       Date:  2019-07       Impact factor: 1.008

3.  Evaluation of an in-clinic dry chemistry analyzer for canine, equine, and feline plasma samples.

Authors:  Katie M Boes; Carolyn A Sink; Melinda S Camus; Stephen R Werre
Journal:  J Vet Diagn Invest       Date:  2018-10-20       Impact factor: 1.279

4.  Evaluation of the i-STAT Alinity v in a veterinary clinical setting.

Authors:  Jasper E Burke; Thuy Hien T Nguyen; Tanya Davis; Amie Koenig; Selena L Lane; Jennifer Good; Benjamin M Brainard
Journal:  J Vet Diagn Invest       Date:  2021-05-28       Impact factor: 1.569

5.  Practical application of Six Sigma management in analytical biochemistry processes in clinical settings.

Authors:  Bingfei Zhou; Yi Wu; Hanlin He; Cunyan Li; Liming Tan; Youde Cao
Journal:  J Clin Lab Anal       Date:  2019-11-27       Impact factor: 2.352

6.  Comparison of a point-of-care serum amyloid A analyzer frequently used in equine practice with 2 turbidimetric immunoassays used in human and veterinary medicine.

Authors:  Julia Kiemle; Sarah Hindenberg; Natali Bauer; Michael Roecken
Journal:  J Vet Diagn Invest       Date:  2021-11-11       Impact factor: 1.279

7.  P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma.

Authors:  Valéria Dékay; Edina Karai; András Füredi; Kornélia Szebényi; Gergely Szakács; Péter Vajdovich
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575

Review 8.  Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.

Authors:  Romy M Heilmann; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.